US OptionsDetailed Quotes
KIND241220P6000
- 0.00
- 0.000.00%
15min DelayClose Nov 27 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest6.00Strike Price0.00Turnover212.50%IV-147.93%PremiumDec 20, 2024Expiry Date3.58Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9383Delta0.1103Gamma0.67Leverage Ratio-0.0030Theta-0.0019Rho-0.63Eff Leverage0.0007Vega
Nextdoor Holdings Stock Discussion
Sign in to post a comment
December to February is typically a unique period in financial markets due to a combination of seasonal trends, holiday spending, tax-related activities, and year-end corporate earnings. Here are some notable historical trends during this period:
1. The Santa Claus Rally (Late December)
The "Santa Claus Rally" refers to a historical tendency for stock markets to perform well in the last week of December and the first two trading days of January. This pattern is ...
1. The Santa Claus Rally (Late December)
The "Santa Claus Rally" refers to a historical tendency for stock markets to perform well in the last week of December and the first two trading days of January. This pattern is ...
17
1
Nextdoor Holdings' share price reflects its promising future growth. However, other factors like its balance sheet strength should be considered, especially as the stock trades around its fair value. The company's positive outlook is encouraging for potential investors.
1
Investors may be overvaluing Nextdoor Holdings given its high P/S ratio and weak projected revenue growth. This could risk share price decline or investors paying an unwarranted premium.
$Nextdoor Holdings (KIND.US)$ doesn't believe in freedom of speech
Despite Nextdoor's promising growth outlook, its overvalued stock suggests it may not be the best time for potential investors to buy. Current shareholders may want to consider selling.
In view of the weaker than expected recovery in the ad market, particularly in the financial services and home services vertical markets, CEO Sarah Friar deems the job cuts necessary to 'right-size' the business, despite the tough decision.
The quarter's results showed slowing growth and missed estimates, leading to a negative view. The downturn is seen by some as an investment opportunity, whereas others urge caution due to concerns about the company's valuation, business qualities, and recent quarterly results. Total Weekly Active Users (WAU) miss was a notable worry.
Gainers:
In reaction to earnings/guidance:
• $Wolfspeed (WOLF.US)$ +22.2%, $Canadian Solar (CSIQ.US)$ +6.5%, $BJ's Wholesale Club Holdings (BJ.US)$ +5.8%, $Cisco (CSCO.US)$ +5.3%, $Keysight Technologies (KEYS.US)$ +4.3%, $Madison Square Garden Sports (MSGS.US)$ +3%, $NetEase (NTES.US)$ +2.7%, $NICE Ltd (NICE.US)$ +2.1%, $Synopsys (SNPS.US)$ + 1.8%
News:
• $Brooge Energy (BROG.US)$ +17.1% (says majority shareholder, BPGIC Holdings, would like to take ...
In reaction to earnings/guidance:
• $Wolfspeed (WOLF.US)$ +22.2%, $Canadian Solar (CSIQ.US)$ +6.5%, $BJ's Wholesale Club Holdings (BJ.US)$ +5.8%, $Cisco (CSCO.US)$ +5.3%, $Keysight Technologies (KEYS.US)$ +4.3%, $Madison Square Garden Sports (MSGS.US)$ +3%, $NetEase (NTES.US)$ +2.7%, $NICE Ltd (NICE.US)$ +2.1%, $Synopsys (SNPS.US)$ + 1.8%
News:
• $Brooge Energy (BROG.US)$ +17.1% (says majority shareholder, BPGIC Holdings, would like to take ...
8
Gainers:
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
11
3
CAN I AT LEAST LEAST LEATHER HOW TO BUY N SELL STOCKS ON THIS BROCHURE MOOMOO 
FOR REAL I DONT GET IT 
Gainers:
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy (CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage (PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology (CRDO.US)$ +10.2% (In reaction ...
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy (CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage (PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology (CRDO.US)$ +10.2% (In reaction ...
19
No comment yet
Mrstocksplitsundae : don't forget good old stock manipulation from insiders and auditors.